Vascular endothelial lesion in patients undergoing bone marrow transplantation

S. Richard*, M. Seigneur, A. Blann, R. Adams, M. Renard, M. Puntous, J. M. Boiron, J. Amiral, J. Reiffers, M. Boisseau

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)

Abstract

Changes in endothelial cell activity are likely to play a role in the thrombotic complications of bone marrow transplantation (BMT) such as the development of veno-occlusive disease. Accordingly, we measured established plasma endothelial cell markers von Willebrand factor (vWf), soluble thrombomodulin (sTM), soluble ICAM-1 (sICAM-1), and possible inducers of these molecules, TNF alpha and elastase, in the plasma of 25 patients, 1 week before as well as 1 and 3 weeks after BMT. Compared to healthy age and sex-matched controls, patients exhibited increased vWf and sTM. One week after transplantation, there were significant increases in vWf and sICAM-1, with a significant fall in elastases. Three weeks after the transplantation, sICAM-1 and, to a lesser extent, vWf increased still further, whereas elastases were unchanged. There were no significant changes in sTM and in TNF alpha through the serial study. Our data suggest that before conditioning, vascular endothelium is damaged by both injury and activation, as seen by the variations of vWf and sTM. After transplantation, the enhancement of this damage seems to be more specifically related to activation, since we observed a strong subsequent increase in vWf and markedly in sICAM-1.

Original languageEnglish
Pages (from-to)955-959
Number of pages5
JournalBone Marrow Transplantation
Volume18
Issue number5
Publication statusPublished - Nov 1996
Externally publishedYes

Keywords

  • Bone marrow transplantation
  • Endothelial injury
  • Soluble ICAM-1
  • Soluble thrombomodulin
  • Von willebrafid factor

Cite this